BSE Live
Dec 03, 16:02Prev. Close
38.84
Open Price
38.84
Bid Price (Qty.)
38.36 (1)
Offer Price (Qty.)
38.91 (175)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Balance Sheet of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 43.79 | 10.95 | 3.91 | 1.57 | 1.57 | |
| Total Share Capital | 43.79 | 10.95 | 3.91 | 1.57 | 1.57 | |
| Reserves and Surplus | 19.05 | 46.69 | 21.38 | 14.78 | 14.03 | |
| Total Reserves and Surplus | 19.05 | 46.69 | 21.38 | 14.78 | 14.03 | |
| Total Shareholders Funds | 62.84 | 57.64 | 25.30 | 16.35 | 15.60 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 3.11 | 2.66 | 3.77 | 3.13 | 9.77 | |
| Deferred Tax Liabilities [Net] | 3.41 | 3.27 | 3.29 | 3.26 | 3.20 | |
| Other Long Term Liabilities | 0.00 | 0.00 | 0.11 | 0.00 | 0.00 | |
| Long Term Provisions | 0.13 | 0.11 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Liabilities | 6.65 | 6.04 | 7.16 | 6.39 | 12.97 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 1.06 | 0.50 | 1.31 | 0.25 | 0.00 | |
| Trade Payables | 9.22 | 7.22 | 34.25 | 8.59 | 5.33 | |
| Other Current Liabilities | 4.27 | 5.65 | 6.94 | 3.54 | 0.00 | |
| Short Term Provisions | 2.74 | 0.79 | 0.00 | 0.00 | 0.86 | |
| Total Current Liabilities | 17.28 | 14.15 | 42.51 | 12.38 | 6.19 | |
| Total Capital And Liabilities | 86.77 | 77.84 | 74.97 | 35.11 | 34.76 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 19.40 | 19.94 | 20.23 | 17.58 | 17.69 | |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Work-In-Progress | 1.95 | 1.66 | 1.66 | 1.66 | 1.66 | |
| Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Fixed Assets | 21.34 | 21.60 | 21.89 | 19.24 | 19.35 | |
| Non-Current Investments | 0.00 | 0.00 | 0.00 | 0.20 | 0.19 | |
| Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Non-Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Total Non-Current Assets | 21.34 | 21.60 | 21.89 | 19.45 | 19.55 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 9.95 | 2.31 | 3.16 | 3.95 | 1.68 | |
| Trade Receivables | 8.77 | 24.51 | 30.19 | 7.40 | 8.90 | |
| Cash And Cash Equivalents | 12.12 | 9.98 | 3.97 | 0.09 | 0.50 | |
| Short Term Loans And Advances | 10.23 | 1.98 | 2.28 | 3.12 | 3.98 | |
| OtherCurrentAssets | 24.36 | 17.45 | 13.48 | 1.11 | 0.14 | |
| Total Current Assets | 65.43 | 56.23 | 53.07 | 15.67 | 15.22 | |
| Total Assets | 86.77 | 77.84 | 74.97 | 35.11 | 34.76 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 1.40 | 1.40 | 1.40 | 0.00 | 0.00 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | -- | -- | -- | -- | -- | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | -- | -- | -- | 0.20 | 0.19 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
24.11.2025
Shukra Pharma Standalone September 2025 Net Sales at Rs 5.88 crore, up 5.8% Y-o-Y
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y